GPRA Data Report: April 2020 Pennsylvania Screening, Brief Intervention, and Referral to Treatment (PA SBIRT) is a five-year initiative that will provide SBIRT services throughout the Commonwealth through September 2021. Funding for the project is granted through the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment (CSAT). PA SBIRT aims to provide SBIRT services to 20,778 unduplicated patients during the grant period. All data is collected and reported in accordance with the Government and Performance Results (GPRA) Act of 2010. The purpose of this report is to outline key findings and recommendations based upon GPRA analyses for the PA SBIRT initiative to date. 6 Active Project Sites 14,866 Unduplicated Screenings → 17,629 GPRA Target → 84.3% Coverage Rate → 85.5% Scored “Negative” (Figure 1) 56,062 Total Screenings Conducted 4,303 Brief Interventions Conducted 797 Connections to Speciality Resources Screening and Feedback, 85.5% Brief Intervention, 11.2% Brief Treatment, 1.2% Referral to Treatment, 1.5% Figure 1. Screening Score Distribution Report Summary • PA SBIRT project sites have provided SBIRT services to 14,866 (84.3%) of the 17,629 unique patients intended to be served to date. This is a 0.81% increase since the month of March 2020. • The overall follow-up enrollment rate is 9.94%, just below the 10% requirement. PERU will work with each site to address this decrease. Patients continue to report significant decreases in days of use after SBIRT services. • EMPOWER 3 Center for Health (EMP – Pg. 3) provided 100% of the necessary brief interventions in April despite workflow modifications. The site will work to increase the screening rate and move forward with opportunities to promote sustainability. • Altoona Family Physicians (AFP – Pg. 4) implemented screening during telehealth appointments in April. The Pregnancy Care Center (PCC – Pg. 5) is exploring opportunities to increase the screening rate. • Primary Health Network (PHN) sites convened a sustainability workgroup. Greenville Community Health Center (GCHC – Pg. 7) is exploring opportunities to increase the screening rate and Sharon Medical Group (SMG – Pg. 6) is exploring methods to improve patient connections to the Care Coordinator. • Allegheny Health Network’s Forbes Family Medicine (FFM – Pg. 8) continues to maintain a high screening rate. The site is working to improve the follow-up enrollment rate and expand screening efforts through telehealth services. Project to Date
8
Embed
GPRA Data Report: April 2020 · 1.2% Referral to Treatment, 1.5% Figure 1. Screening Score Distribution Report Summary • PA SBIRT project sites have provided SBIRT services to 14,866
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
GPRA Data Report: April 2020
Pennsylvania Screening, Brief Intervention, and Referral to Treatment (PA SBIRT) is a five-year initiative that will provide SBIRT services
throughout the Commonwealth through September 2021. Funding for the project is granted through the Substance Abuse and Mental
Health Services Administration (SAMHSA) Center for Substance Abuse Treatment (CSAT).
PA SBIRT aims to provide SBIRT services to 20,778 unduplicated patients during the grant period. All data is collected and reported in
accordance with the Government and Performance Results (GPRA) Act of 2010. The purpose of this report is to outline key findings and
recommendations based upon GPRA analyses for the PA SBIRT initiative to date.
6 Active Project Sites
14,866 Unduplicated Screenings
→ 17,629 GPRA Target
→ 84.3% Coverage Rate
→ 85.5% Scored “Negative” (Figure 1)
56,062 Total Screenings Conducted
4,303 Brief Interventions Conducted
797 Connections to Speciality Resources
Screening
and
Feedback,
85.5%
Brief
Intervention,
11.2%
Brief
Treatment,
1.2%Referral to
Treatment,
1.5%
Figure 1. Screening Score Distribution
Report Summary
• PA SBIRT project sites have provided SBIRT services to 14,866 (84.3%) of the 17,629 unique patients intended
to be served to date. This is a 0.81% increase since the month of March 2020.
• The overall follow-up enrollment rate is 9.94%, just below the 10% requirement. PERU will work with each site
to address this decrease. Patients continue to report significant decreases in days of use after SBIRT services.
• EMPOWER3 Center for Health (EMP – Pg. 3) provided 100% of the necessary brief interventions in April despite
workflow modifications. The site will work to increase the screening rate and move forward with opportunities
to promote sustainability.
• Altoona Family Physicians (AFP – Pg. 4) implemented screening during telehealth appointments in April. The
Pregnancy Care Center (PCC – Pg. 5) is exploring opportunities to increase the screening rate.
• Primary Health Network (PHN) sites convened a sustainability workgroup. Greenville Community Health
Center (GCHC – Pg. 7) is exploring opportunities to increase the screening rate and Sharon Medical Group
(SMG – Pg. 6) is exploring methods to improve patient connections to the Care Coordinator.
• Allegheny Health Network’s Forbes Family Medicine (FFM – Pg. 8) continues to maintain a high screening rate.
The site is working to improve the follow-up enrollment rate and expand screening efforts through telehealth
services.
Project to Date
2
The PA SBIRT initiative is committed to following-up with 10% of patients who score in the BI, EI, or RT ranges. CSAT requires grantees to
conduct a 6-month follow-up interview with at least 80% of these patients. Six-month follow-up interviews can be conducted between 5
and 8 months after initial patient intake.
23% increase in patients who report no use at follow-
up compared to reported use at intake (Figure 2).
28% 33%
32% 22%
33%
16%
14%
37%
0%
25%
50%
75%
100%
Intake (n=179) Follow-Up (n=179)
Figure 2. Substance Use at Intake &
Follow-Up
Alcohol Only Drugs Only
Both Alcohol and Drugs No Use
Patient Follow-Up
Focus of the Month
• The results reported on the left (Figure 3) show a decrease
in almost 2 and a half days of alcohol consumption and a
decrease in 5 and a half days of drug use when asked about
frequency of use in the past 30 days at follow-up.
• Complete and immediate abstinence is not always a
realistic strategy when decreasing substance use.
• This finding supports SBIRT services as a harm reduction
strategy to gradually decrease a change in use behavior
2 of 6 implementation sites have enrolled at least
10% of eligible patients in follow-up. 2,153 Eligible for Enrollment
→ 214 Paients Enrolled
→ 9.94% Enrollment Rate
198 Eligible for Interview
→ 179 Interviews Completed
→ 90.4% Completion Rate
17% decrease in patients who report poly-substance
use at follow-up compared to reported use at intake.
Patients who receive SBIRT services report
significant decreases in reported days of substance
use between the initial appointment and 6-month
follow-up interview.
6.7
10.67
4.38
5.19
0 2 4 6 8 10 12
Alcohol
Drugs
Figure 3. Average Days of Use in Last 30
Days, Including Abstentees (N=192)
Follow-Up Intake
3
16,076 Screens to Date
12.7% Eligible Patients
Enrolled in Follow-Up
Success from April Goal for May
EMPOWER3 Center for Health (EMP) began SBIRT implementation on March 6, 2017. The site has reached a steady state
of implementation, as clinical staff screened 90% of patients over the past month. The site continues to move forward
with conversations and actions to promote SBIRT sustainability.